Aelan Cell Technologies articles
Although you may think of your body as a fairly permanent structure, most of it is in a state of constant flux, as old cells are discarded and new ones generated in their place. Each type of tissue has its own turnover time, depending in part on the workload endured by its cells.
Adult stem cells are at the core of your body`s natural renewal system; 50 to 70 million cells are discarded and replaced daily.
Cancer survival rates decrease with age, in part because the efficacy of cancer therapies declines in older individuals. Chemotherapy and radiotherapy wreak havoc on the immune system, kill both healthy and cancerous cells alike and cause a buildup of cellular waste in the tissue. This residual waste needs to be either removed from the
SAN FRANCISCO, CA--(Marketwired - Sep 11, 2015) - Aelan Cell Technologies announced today the addition of Meenakshi Gaur, Ph.D. to their stem cell clinical program. Dr. Gaur will serve as the Director of Research and Development of the Stem Cell Program, leading a research team that will develop technology aimed at rejuvenation of human mesenchymal stem cells for clinical applications.
"Dr. Gaur is a terrific addition to the world-class scientific team we are building, one with the kn
San Francisco, CA - Since the classical studies of Jacob and Monod in the early 1960s, it has been evident that genome sequences contain not only blueprints for genes and the proteins that they encode, but also the instructions for a coordinated regulatory program that governs when, where and to what extent these genes and proteins are expressed. The execution of this regulatory code is what allows for the creation of very different cell- and tissue-types from the same set of genetic instruct
San Francisco, CA –Aelan Cell Technologies, with an international research team, today released a study that reveals that age is a key determining factor in the efficacy of cell-based or pharmacological treatments. The study, published in the advanced online publication of Oncotarget: Gerotarget